Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry

NEW YORK, April 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry

http://www.reportlinker.com/p0487118/Pharmaceutical-Key-Trends-2011---Brand-Erosion-Post-Patent-Expiry.html

Introduction

Pharma is facing slowing sales growth in the developed pharmaceutical markets, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means equal across countries, prescribing setting, therapy area and formulation type; factors which are of key importance when managing and forecasting branded drug sales.

Features and benefits

* Analyzes brand erosion (in terms of volume and value) in the US, Japan, France, Germany, Italy, Spain, UK, Australia China and Russia

* Assesses brand erosion across the two major prescribing settings (retail and hospital)

* Examines brand erosion across the various different therapy areas

* Analyzes brand erosion according to drug formulation (oral, oral long lasting, parenteral and other formulation types)

Highlights

Brands tended not to experience generic erosion in China following patent expiry since they often face generic competition from the outset, and instead continue to grow both in terms of volume and value.

Brand erosion was greater in terms of speed and severity in the hospital setting most likely reflecting the greater brand loyalty among patients in the retail setting.

In terms of erosion by therapy areas, sales and volume erosion was the greatest among infectious disease, oncology, and cardiovascular small molecule brands.

Your key questions answered

* Evaluate the evolving prescription pharmaceutical landscape and how this is being impacted by generics

* Quantify sales and volume erosion across 10 major pharmaceutical markets according to prescribing setting, therapy areas, and drug formulation

* Assess drivers and resistors for the uptake of generic drugs in each market

Executive Summary

Introduction

Strategic Scoping and Focus

Key Findings

Brand erosion by country

Brand erosion by prescribing setting (retail versus hospital)

Brand erosion by therapy area

Brand erosion by formulation

Overview of drugs analyzed

Related Reports

Upcoming related reports

2. BRAND EROSION ACROSS THE WORLD'S MAJOR MARKETS

Overview of brand erosion across the world's major markets

3. GENERICS MARKET DYNAMICS

Comparison of generic penetration across major pharmaceutical markets

Generics volume uptake

Generics value uptake

Generics market size

4. GENERICS DRIVERS AND RESISTORS

Overview of Generics Drivers and Resistors

US – Generics drivers and resistors

Japan – Generics drivers and resistors

France – Generics drivers and resistors

Germany – Generics drivers and resistors

Italy – Generics drivers and resistors

Spain – Generics drivers and resistors

UK – Generics drivers and resistors

China – Generics drivers and resistors

Brazil – Generics drivers and resistors

India – Generics drivers and resistors

Russia – Generics drivers and resistors

Australia – Generics drivers and resistors

5. BRAND EROSION IN THE RETAIL AND HOSPITAL SETTING

Overview of brand erosion in the retail and hospital setting

Retail and hospital erosion by country

6. BRAND EROSION BY THERAPY AREA

Overview of brand erosion by therapy area

Brand erosion by therapy area – Infectious diseases

Brand erosion by therapy area – Cardiovascular

Brand erosion by therapy area – Oncology

Brand erosion by therapy area – Central Nervous System

Brand erosion by therapy area – Respiratory

Brand erosion by therapy area – Metabolic disorders

Brand erosion by therapy area – Immunology and inflammation

Brand erosion by therapy area – Other

7. BRAND EROSION BY DRUG FORMULATION

Overview of brand erosion by drug formulation

Brand erosion by drug formulation – Oral

Brand erosion by drug formulation – Oral long lasting

Brand erosion by drug formulation – Parenteral

Brand erosion by drug formulation – Other formulations

8. BIBLIOGRAPHY

Publications and online articles

Datamonitor reports and products

APPENDIX

Exchange rates used in this report

Brand erosion – methodology

Datamonitor prescription pharmaceutical definition and therapy area classification

To order this report:

: Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker